Bicara Therapeutics Inc. (BCAX) ROE
- 2026-06-30: ROE -39.54%.
- 2026-03-31: ROE -30.61%.
- 2025-12-31: ROE -34.36%.
- 2025-09-30: ROE -30.17%.
Complete source-backed roe history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -39.54% |
| 2026-03-31 | -30.61% |
| 2025-12-31 | -34.36% |
| 2025-09-30 | -30.17% |
| 2025-06-30 | -23.59% |
| 2025-03-31 | -20.12% |
| 2024-12-31 | -13.82% |
| 2024-09-30 | -11.67% |
| 2024-06-30 | 37.10% |
| 2024-03-31 | 35.66% |
| 2023-12-31 | 34.94% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -34.36% |
| 2024-12-31 | -13.82% |
| 2023-12-31 | 34.94% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |